Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 11297233.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Various mechanisms have been implicated in nitrogen mustard drug resistance. The role of these mechanisms in the development of chlorambucil drug resistance in chronic lymphocytic leukemia (CLL) is discussed. We review these mechanisms with emphasis on the emerging role of DNA repair, and specifically, recombinational repair. Inhibition of these repair processes may lead to new therapies, not only in CLL, but in other malignancies as well.
Medical subject headings
- Antineoplastic Agents, Alkylating
- Chlorambucil
- DNA Repair
- Drug Resistance, Neoplasm
- Leukemia, Lymphocytic, Chronic, B-Cell
- Mechlorethamine